Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Endocr Relat Cancer. 2018 Jan 25;25(4):437–451. doi: 10.1530/ERC-17-0447

Table 1.

Complete Short Tandem Repeat profiling (STR) of new ACC models and respective human tissues

Sample AMEL CSF1PO D13S317 D16S539 D18S51 D21S11 D3S1358 D5S818 D7S820 D8S1179 FGA Penta D Penta E TH01 TPOX vWA
CU-ACC2 pt tumor × 11, 12 13 11, 12 19, 20 29 14 11, 12 8 13, 14 24 14 11 9.3 8 16, 18, 21
CU-ACC2 cell line × 11, 12 13 11, 12 19, 20 29 13, 14 11,12 8 13, 14 24 14 11 9.3 8 16, 18,20
CU-ACC2 PDX × 11, 12 13 11, 12 19, 20 29 13, 14 11,12 8 13, 14 24 14 11 9.3 8 16, 18, 19, 20
Sample AMEL CSF1PO D13S317 D16S539 D18S51 D21S11 D3S1358 D5S818 D7S820 D8S1179 FGA Penta D Penta E TH01 TPOX vWA
CU-ACC1 pt blood × 12 9, 13 9, 12 15, 21 29 15, 17 9, 12 8, 10 13, 14 19, 20 12, 13 12, 17 7, 9.3 9, 11 18
CU-ACC1 cell line × 12 9, 13 9, 12 15, 21 29 15, 17 12 8 13, 14 19, 20 12, 13 12, 17 7 9, 11 18
CU-ACC1 PDX × 12 9, 13 9, 12 15, 21 29 15, 17 12 8 13, 14 19, 20 12, 13 12, 17 7 9, 11 18